The sixth round of the 2024 Italian F.4 Championship, the penultimate event of the season, has concluded in Barcelona. The Spanish weekend was decisive for the fate of the Italian F.4 Championship, with the final closure of the drivers’ standings and Freddie Slater’s dominant triumph. The race that brought the weekend to a close marked the first win for Jack Beeton, the Australian driver from US Racing who has been one of the season’s revelations. Beeton, after standing on the second step of the podium seven times this year—most recently in Race 1 at Barcelona—finally celebrated from the top spot.

The 2024 Ginetta Junior champion will receive a £50,000 scholarship towards a seat in the 2025 GB4 Championship, it was confirmed today (Friday 26 April). Ginetta Cars and GB4 promoter MotorSport Vision (MSV) will jointly contribute to the prize fund – one of the largest ever seen at this level of UK motorsport.

Rafael Villagómez steps up the motorsport ladder as he readies himself to compete in the 2024 edition of the FIA F2 Championship. With that, Villagómez completes VAR’s F2 driver line-up, set to race alongside his recently announced team-mate Enzo Fittipaldi.

Charouz Racing System is glad to announce the renewal of the agreement with Enzo Fittipaldi for the upcoming FIA Formula 2 season. The Brazilian driver completes the Czech team's 2022 lineup together with Cem Bölükbasi, announced last month. For Fittipaldi this will be his first full season in the championship, having made his debut last year in Monza’s round.

Record numbers for the eighth edition of the Italian F.4. 37 single-seater will be deployed at the start of Paul Ricard race, 12 the teams involved and 18 the nationalities represented from 4 different continents

The Ferrari Driver Academy is pleased to announce that two new drivers are joining the Maranello marque’s racing driver training and development programme, which has now been operational for eleven years. The drivers in question are Arthur Leclerc and Dino Beganovic, whose 2019 performances showed they have what it takes to be part of the FDA.